For filings with the FSA include the annex< ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />
GENEVA, SWITZERLAND–(Marketwired – April 15, 2013) - Ares Life Sciences, a healthcare-focused investment group, announced today that it has signed a definitive agreement to acquire 100% of the share capital of Planet Biopharmaceuticals, Inc., including its wholly owned subsidiary Antigen Laboratories, Inc., a producer of allergen extracts, who works closely with the ENT (Ear, Nose and Throat) specialist community in the United States. Closing of the transaction is subject to certain closing conditions.
More here: Ares Life Sciences to Acquire Antigen Laboratories, Inc., in the United States
TORONTO, ONTARIO–(Marketwire – March 29, 2013) – Lynnwood Capital Inc. (“Lynnwood“) (TSX VENTURE:LCI.P), a capital pool company as defined under Policy 2.4 of the TSX Venture Exchange (the “TSXV“), is pleased to announce that it has entered into an agreement (the “Revised Letter Agreement“) dated March 18, 2013 and executed March 20, 2013 for the arm’s length acquisition of 100% of the common shares (the “Tantalex Shares“) of Tantalex Corporation (“Tantalex“). The Revised Letter Agreement supersedes and replaces the letter agreement (the “Letter Agreement“) dated May 9, 2012 between Lynnwood and Tantalex, previously announced on May 9, 2012, June 11, 2012, July 9, 2012 and October 4, 2012, which was meant to qualify as Lynnwood’s “qualifying transaction” as defined by the TSXV.
Read this article: Lynnwood Capital Announces Update on Proposed Transaction With Tantalex Corporation
SAGINAW, MI–(Marketwire – Mar 16, 2013) – HPIL Holding (the “Company”) (OTCQB: HPIL) is pleased to announce that it sold 16,000 shares of treasury common stock (the “Common Stock”) at a price of $5.10 per share for a total purchase price of $81,600. The Common Stock was sold in a private transaction. The sale of Common Stock was made pursuant to a Stock Purchase Agreement made by and between HPIL Holding and an investor dated February 27, 2012.
Read more: HPIL Holding Announces Sale of Stock
< ?xml version="1.0" encoding="UTF-8"?>
Medbox Demonstrates How Their Systems Will Be Used in San Diego Medical Marijuana Dispensaries
Company also announced they will be hosting a free educational seminar in San Diego
HOLLYWOOD, Calif., March 8, 2013
HOLLYWOOD, Calif., March 8, 2013 /PRNewswire/ — Medbox, Inc. (OTC Markets: MDBX) (www.medboxinc.com), announced that due to the outpouring of media requests regarding the dispensaries the company is establishing for its new and existing consulting clients in San Diego, a further clarification is needed to aide in the public’s understanding of how these machines are used. To that end the company has re-released two demo clips that accurately describe how the system works in medical marijuana dispensaries. Most notably, the company clarified that the machines are at the control of and only accessible by licensed dispensary operators and are placed behind-the-counter in a secured dispensing room within the dispensary. The machines take the place of over-the-counter cash transactions and ensure that inventory, safety, security, and the medicine itself is kept in sanitary conditions.
GENEVA, SWITZERLAND–(Marketwire – March 8, 2013) - Ares Life Sciences, a healthcare-focused investment group, announced today that it has signed a definitive agreement to acquire 100% of the share capital of Albion Medical Holdings, Inc., including its wholly owned subsidiary GREER® Laboratories, Inc., a leader in allergy immunotherapy in the United States. Closing of the transaction is subject to U.S. regulatory approvals and certain closing conditions.
More: Ares Life Sciences to Acquire GREER(R) Laboratories, Inc., a Leader in Allergy Immunotherapy in the United States
TORONTO, ONTARIO–(Marketwire – March 1, 2013) – Commonwealth Silver and Gold Mining Inc. (“Commonwealth Silver” or the “Company”) is pleased to announce that it has purchased 2,225,000 common shares of Goldeye Explorations Limited (“Goldeye”) in a private transaction at $0.10 per common share (the “Transaction”). The Transaction was effected by way of a share exchange, whereby the Company issued 296,667 common shares (pre-stock dividend) to Pinetree Resource Partnership (“Pinetree”) in exchange for the 2,225,000 common shares of Goldeye.
Go here to see the original: Commonwealth Silver Acquires a 10.09% Interest in Goldeye Explorations Limited Through Share Exchange
VANCOUVER, BRITISH COLUMBIA–(Marketwire – Feb. 20, 2013) - Bucking Horse Energy Inc. (TSX:BUC) (“Bucking Horse” or the “Company“) announces that at the Company’s Special Meeting held on February 15, 2013, its shareholders adopted a special resolution authorizing the sale of the Company’s developed well-bore interests (the “Assets“) in the Pinedale field in Wyoming to FPR Pinedale LLC. The transaction was previously announced in the Company’s news release dated December 13, 2012 and described in its information circular dated January 16, 2013. The Assets include 66 oil and gas wells and associated petroleum and natural gas production rights being sold for a purchase price of US$61,000,000; the Purchase and Sale Agreement has an effective date of August 1, 2012. The transaction is scheduled to close on or before February 28, 2013 and is subject to approval by the secured debt holders and the Toronto Stock Exchange, as well as customary closing conditions.
Excerpt from: Bucking Horse Energy Inc. Announces Results of Special Meeting